Stocks or ETFs side by side: scores, returns, risk, valuation and what they hold.
| Measure | AZNAstraZeneca PLC | GILDGilead Sciences, Inc. |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Country | United Kingdom | United States |
| Market cap | $290B | $212B |
| Price | $186.76 | $170.87 |
| Last day | −1.39% | +0.92% |
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN analysis and Q-Scores →, a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients.
GILD analysis and Q-Scores →Data as of 2026-10-13. Not investment advice.